QQ客服 官方微博 反馈留言

浏览/检索结果: 共3条，第1-3条 帮助 限定条件 发表日期：2018     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Pharmacological characterization of human beta-defensins 3 and 4 on potassium channels: Evidence of diversity in beta-defensin-potassium channel interactions 期刊论文 PEPTIDES, 2018, 卷号: 108 作者:  Zhao, Yonghui;  Xie, Zili;  Feng, Jing;  Li, Wenxin;  Gao, Zhijian 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05 beta-Defensin  Potassium channel  Kv1.3 channel  Pore-blocking  Interaction mode  Interaction mechanism   EGFR-targeting, beta-defensin-tailored fusion protein exhibits high therapeutic efficacy against EGFR-expressed human carcinoma via mitochondria-mediated apoptosis 期刊论文 ACTA PHARMACOLOGICA SINICA, 2018, 卷号: 39, 期号: 11, 页码: 1777-1786 作者:  Liu, Wen-Juan;  Liu, Xiu-Jun;  Xu, Jian;  Li, Liang;  Li, Yi 收藏  |  浏览/下载：13/0  |  提交时间：2019/12/11 defensin  recombinant protein  EGFR-targeting  lidamycin apoprotein  mitochondria-mediated apoptosis  human epidermoid carcinoma A431 cells  human lung carcinoma A549 cells  human lung carcinoma H460 cells   Enediyne-activated, EGFR-targeted human beta-defensin 1 has therapeutic efficacy against non-small cell lung carcinoma 期刊论文 LABORATORY INVESTIGATION, 2018, 卷号: 98, 期号: 12, 页码: 1538-1548 作者:  Liu, Wen-juan;  Zhu, Kun-li;  Xu, Jian;  Wang, Jia-lin;  Zhu, Hui 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/11